Presidential Greeting - American Society for Laser Medicine and ...

More documents

Recommendations

Info

70 LATE-BREAKING ABSTRACT 2011 Annual Conference Pre-Conference Courses: March 30-31, 2011 Annual Conference: April 1-3, 2011 Gaylord Texan TM Resort and Convention Center Grapevine, TX 5:02 pm – 5:07 pm PULSE STACKING WITH A 1450nm LASER CAN INCREASE DEPTH OF TREATMENT Arisa Ortiz, William Lewis, R. Rox Anderson, University of California, Irvine, CA, Wellman Center for Photomedicine, Boston, MA •Content discusses non-FDA approved device or off-label use 5:08 pm – 5:21 pm Q&A 5:22 pm – 5:27 pm 85 HISTOLOGICAL EVALUATION OF A NON-ABLATIVE 1940nm FRACTIONAL LASER E. Victor Ross 1 , Chad Tingey, Yacov Domankevitz 2 , Kevin Schomacker 2 , James Hsia 2 , Scripps Clinic, San Diego, CA, Candela, Wayland, MA 1 Financial grant, equipment, and honoraria from Candela 2 Salary from Candela •Content discusses non-FDA approved device or off-label use 5:28 pm – 5:33 pm (ePoster available) Cutaneous Laser Surgery Session Saturday, April 2, 2011 86 CLINICAL RESULTS OF NON-ABLATIVE FRACTIONAL PHOTOTHERMOLYSIS FOR HOME-USE TREATMENT OF PHOTODAMAGED SKIN Christopher Zachary 1 , Marieke van Grootel, Tom Nuijs, Kerrie Jiang, Steven Struck, University of California, Irvine, CA, Philips Research, Eindhoven, The Netherlands, Solta Medical, Hayward, CA, The Struck Clinic, Palo Alto, CA 1 Travel expenses and educational support from Solta •Content discusses non-FDA approved device or off-label use 5:34 pm – 5:39 pm 87 EFFECTS OF DEVIATION FROM FOCAL PLANE ON LESION DEPTH AND DIAMETER FOR ABLATIVE FRACTIONAL PHOTOTHERMOLYSIS Garuna Kositrana 1 , Henry Chan 2 , Dieter Manstein 3 , Wellman Center for Photomedicine, Boston, MA 1 Research grant from Lumenis 2 Consulting fees and equity position with Lumenis 3 Consulting fees from Eleme, Quantel, Zeltiq; research grant from Lumenis; royalties from Candela, Elemé, Solta, Zeltiq, Zimmer; equity position with Zeltiq •Content discusses non-FDA approved device or off-label use 5:40 pm – 5:45 pm 88 PSEUDOMELANOMA FOLLOWING FRACTIONAL CO2 LASER RESURFACING Deborah Sarnoff 1 , Robert Gotkin 1 , Ritu Saini, NYU Medical Center, New York, NY 1 Equipment from Cynosure and DEKA 5:46 pm- 5:51 pm 89 ULCERATION OF MATURE SURGICAL SCARS FROM NON-ABLATIVE 1550nm FRACTIONAL LASER TREATMENTS ASSOCIATED WITH INTRA-LESIONAL LIDOCAINE INJECTIONS Gary Chuang�, Zeina Tannous, Mathew Avram, Wellman Laboratories of Photomedicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA 5:52 pm – 5:57 pm 227 ABLATIVE FRACTIONAL RESURFACING FOR TATTOO REMOVAL Omar Ibrahimi, Fernanda Sakamoto, Mathew Avram, R. Rox Anderson, Wellman Center for Photomedicine, Boston, MA •Content discusses non-FDA approved device or off-label use 5:58 pm – 6:15 pm Q&A �Recipient of ASLMS travel grant.
2011 Annual Conference Pre-Conference Courses: March 30-31, 2011 Annual Conference: April 1-3, 2011 Gaylord Texan TM Resort and Convention Center Grapevine, TX Photobiomodulation – Texas 4-6 3:45 pm – 5:30 pm Directors: Juanita J. Anders, Ph.D., Michael Hamblin, M.D. 3:45 pm – 4:19 pm 4:20 pm – 4:29 pm 4:30 pm – 4:39 pm (ePoster available) 4:40 pm – 4:44 pm 4:45 pm – 4:54 pm (ePoster available) 4:55 pm – 4:59 pm 5:00 pm – 5:09 pm 5:10 pm – 5:14 pm 5:15 pm – 5:24 pm 5:25 pm – 5:30 pm �Recipient of ASLMS travel grant. Photobiomodulation Session Saturday, April 2, 2011 PHOTOBIOMODULATION: CLINICAL STUDIES INVITED SPEAKER TRANSCRANIAL LASER THERAPY IN THE TREATMENT OF ALZHEIMER’S DISEASE: A TRANSGENIC MOUSE MODEL Luis De Taboada, PhotoThera, Inc., Carlsbad, CA Discussion 158 A NEW POSSIBILITY TO TREAT SEVERE TRACHEAL STENOSIS APPLYING LOW LEVEL LASER THERAPY: PILOT STUDY Nathali Pinto, Tatiana Magacho, Mara Pereira, M. Cristina Chavantes, University of São Paulo, São Paulo, Brazil, Pitagoras University, Vila Velha, Brazil •Content discusses non-FDA approved device or off-label use Discussion 160 INNOVATIVE METHOD TO IMPROVE EFFICACY AND TOLERABILITY OF PDT TREATMENTS Carl Thornfeldt 1 , CT Derm, Fruitland, ID 1 Stockholder with CT Derm; salary from Episciences •Content discusses non-FDA approved device or off-label use Discussion 161 A PROSPECTIVE SPLIT-FACE DOUBLE-BLIND RANDOMIZED PLACEBO- CONTROLLED TRIAL TO ASSESS THE EFFICACY OF LIGHT-EMITTING DIODE POSTFRACTIONAL ABLATIVE LASER FOR SKIN REJUVENATION Valeria Campos, Juliana Jordao�, Tatiana Cordero, Clinica Valeria Campos, Jundiai, Brazil, Curitiba, Brazil, Campinas, São Paulo, Brazil •Content discusses non-FDA approved device or off-label use Discussion 162 SAFETY AND EFFICACY OF FOOTLASER TREATMENT OF ONYCHOMYCOSIS IN PRIVATE PRACTICE Michael Uro, Laura Uro, Michael Abrahams, Martine Abrahams, Robert Grzywacz, Foot Doctor Laser Center, Sacramento, CA, The London Nail Laser Clinic, London, England, Las Vegas, NV Discussion 71
Page 1 and 2:
Presidential Greeting As a former r
Page 3 and 4:
What’s New for 2011! 2011 Annual
Page 5 and 6:
AWARD CRITERIA 2011 Annual Conferen
Page 7 and 8:
6:30 am - 5:00 pm Registration - Te
Page 9 and 10:
6:00 am - 6:00 pm 6:30 am - 8:00 am
Page 11 and 12:
6:30 am - 12:30 pm 6:30 am - 8:00 a
Page 13 and 14:
2011 Annual Conference Pre-Conferen
Page 15 and 16:
Page 17 and 18:
Fundamentals of Lasers in Health Ca
Page 19 and 20: 2011 Annual Conference Pre-Conferen
Page 21 and 22: Clinical Application Courses (Inter
Page 27 and 28: Clinical Application Course (Interm
Page 31 and 32: Conference Plenary Session Friday,
Page 39 and 40: LATE-BREAKING ABSTRACT 2011 Annual
Page 45 and 46: 4:30 pm - 4:39 pm (ePoster availabl
Page 49 and 50: MINI SYMPOSIA: TECHNOLOGY AND TREAT
Page 51 and 52: 1:00 pm - 1:09 pm 1:10 pm - 1:14 pm
Page 69: 2011 Annual Conference Pre-Conferen
Page 77 and 78: Expert Panels Sunday, April 3, 2011
Page 79 and 80: Clinical Application Course (Interm
Page 81 and 82: 2009 ASLMS STUDENT RESEARCH GRANT R
Page 91 and 92: 9:12 am - 9:17 am 9:18 am - 9:19 am
Page 95 and 96: ePosters 2011 Annual Conference Pre
Page 97 and 98: ePosters 2011 Annual Conference Pre
Page 99 and 100: ePosters RESEARCH (BASIC SCIENCE) 2
Page 103 and 104: Astanza Laser .....................
Page 105 and 106: CuraMedix, LLC ....................
Page 107 and 108: Envy Medical ......................
Page 109 and 110: Innovative Optics, Inc. ...........
Page 111 and 112: VÉÑÑxÜ fÑÉÇáÉÜ ASLMS INDU
Page 113 and 114: Obagi Medical Products ............
Page 115 and 116: Sandstone Medical Technologies ....
Page 117 and 118: The Laser Network, LLC ............
Page 119 and 120: Exhibitor Listing Acuderm, Inc. ...
Page 121 and 122:
Page 123 and 124:
Ken Day, Ph.D. ASLMS Employee Since
Page 125 and 126:
BEST STUDENT/RESIDENT CUTANEOUS LAS
Page 127 and 128:
Page 129 and 130:
Leon Goldman Memorial Award 2011 An
Page 131 and 132:
Page 133 and 134:
ePOSTER SECTION CHAIR Emil A. Tangh
Page 135 and 136:
Page 137 and 138:
Page 139 and 140:
(INSERT CME FORMS) 2011 Annual Conf
Page 141 and 142:
Page 143 and 144:
Continuing Education Credits 2011 A
Page 145 and 146:
Annual Conference Objectives 2011 A
Page 147 and 148:
Page 149 and 150:
ASLMS Learner Bill of Rights 2011 A
Page 151 and 152:
Abrahams, Martine, 71 Abrahams, Mic
Page 153 and 154:
Fabi, Sabrina, 69,95,97 Fadel, Maha
Page 155 and 156:
Lee, Kyung goo, 74 Lee, Sang geun,
Page 157 and 158:
Rosende, Laura, 99 Ross, E. Victor,
Page 159 and 160:
Xu, Xue-Gang, 81 Xu, Yang-Yi, Xuan,
Page 161 and 162:
#1 AMERICAN SOCIETY FOR LASER MEDIC
Page 163 and 164:
after administration of targeted GN
Page 165 and 166:
educe central TM endothelial cell d
Page 167 and 168:
etween the fiber diameters. The abl
Page 169 and 170:
Background: The microvasculature is
Page 171 and 172:
patient basis for increased efficac
Page 173 and 174:
are still needed to prove and compa
Page 175 and 176:
#46 CUTANEOUS LASER SURGERY INVESTI
Page 177 and 178:
#53 NON-ABLATIVE FRACTIONAL LASER R
Page 179 and 180:
Results: All patients were subjecti
Page 181 and 182:
#66 NON-ABLATIVE FRACTIONAL RESURFA
Page 183 and 184:
subjects improved, while the majori
Page 185 and 186:
Results: At the 3-month follow-up v
Page 187 and 188:
Background: Recently a specially de
Page 189 and 190:
intra-lesional lidocaine injection
Page 191 and 192:
Results: Average treatment times fo
Page 193 and 194:
Results: At the 1-month follow-up,
Page 195 and 196:
UC Davis Medical Center, Sacramento
Page 197 and 198:
#115 OPTIMUM CHOICE OF IRRADIATION
Page 199 and 200:
treatment associated with oral anti
Page 201 and 202:
#131 RADIAL ACOUSTIC WAVES FOR THE
Page 203 and 204:
energy delivery for similar indicat
Page 205 and 206:
day. LLLT, P1 LLLT, P2 LLLT, S1, S2
Page 207 and 208:
Study: The effects of RLED and resv
Page 209 and 210:
positive improvement, ranged from 5
Page 211 and 212:
#170 MECHANISMS OF ANTIMICROBIAL PH
Page 213 and 214:
SURGICAL APPLICATIONS INTERSTITIAL
Page 215 and 216:
preserved and denaturated, inducing
Page 217 and 218:
dermal plexus of vessels. Skin tigh
Page 219 and 220:
tattoos. The purpose of this study
Page 221 and 222:
manufacturer; 4-11.8 J/cm 2 measure
Page 223 and 224:
Study: The primary objective of thi
Page 225 and 226:
standardized treatment protocol sup
Page 227 and 228:
Conclusion: This new total combinat
Page 229 and 230:
etween two groups for MI after trea
Page 231 and 232:
same parameters of 30 minutes (cool
Page 233 and 234:
Q-switched Alexandrite laser (6.5 J
Page 235 and 236:
Study: Institutional based prospect
Page 237 and 238:
Results: High improvement by subjec
Page 239 and 240:
ICAM-1 and VCAM-1. Clinical and his
Page 241 and 242:
Results: OCT images showed a partia
Page 243 and 244:
American Society for Laser Medicine
Page 245 and 246:
Page 247 and 248:
Page 249 and 250:
Page 251 and 252:
Page 253 and 254:
Page 255 and 256:
Page 257 and 258:
Page 259 and 260:
Page 261 and 262:
Page 263 and 264:
Page 265 and 266:
Page 267 and 268:
Page 269 and 270:
and randomized to receive up to fou
Page 271 and 272:
Harish Krishnamoorthi, Jonathan Cay
Page 273 and 274:
Laser has proven to be a safe new o
Page 275:
Wounds were treated using PCRB and
show all

Presidential Greeting - American Society for Laser Medicine and ...

Create successful ePaper yourself

Delete template?

Save as template?